



Supplementary Figure 1:  Kinetic profiles of IAPP self-assembly. a, Three representative kinetic 
profiles for a standard reaction of 10 µM IAPP catalysed by the presence of 630 µM LUVs 
(DOPG:DOPC, 1:1, 100 nm) (inset) A representative sigmoid fit (magenta) used to extract reaction 
midpoints, t50.   b, Representative comparison of the kinetic profiles of (10 µM) IAPP fibrillation in the 
absence (black) and presence (red) of 630 µM LUVs. All experiments were conducted at least in 
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Supplementary Figure 2: Effect of lipid headgroup anionic content on the catalysis of IAPP self-
assembly. Representative (a) and statistics (b) of reaction midpoints, t50, for 10 μM IAPP fibre 
formation reactions catalysed by extruded unilamellar vesicles (100 nm, 630 μM monomer units, with 
DOPG:DOPC at the indicated ratio.  Also shown are repeated reactions preformed in the presence of 
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Supplementary Figure 3:  Imaging of ADM-116 inhibited assembly.  Negative stain TEM images of 
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Supplementary Figure 4:  Comparison of INS-1 and COS-1 rescue by ADM-116 and ADM-3.   
Statistics of toxic effect of IAPP applied to INS-1 cells or COS-1 cells and measured 48 h later using 
CTB.  Data is shown for IAPP alone and with equimolar ratio of the indicated small molecule co-added 
at a 1:1 ratio. Data is renormalised to the toxicity induced only by IAPP.  Error bars are standard 
deviations from three sets of experiments conducted on separate occasions with eight technical repeats.  
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Supplementary Figure 5:  Rescue of INS-1 cells from IAPP induced toxicity.  Statistics of toxic 
effect of 13 µM IAPP applied at time-zero to INS-1 cells and measured 48 h later using CTB.  Data is 
shown for IAPP alone and with equimolar mixtures of the indicated small molecule. Small 
molecule:IAPP complexes were permitted to form over a period of 14 h prior to adding to cells. In (a) 
data is presented as % toxicity where the lower baseline is the CTB response measured by addition of 
IAPP-free buffer (vehicle).  For the upper baseline, DMSO at 10% is used as it is wholly toxic to INS-1 
cells.  CTB response at this condition sets the value of 100% toxicity.  Note that in other publications, 
analogous data is sometimes expressed as viability (100% - %toxicity).  In (b), the data in (a) is shown 
renormalised to the toxicity induced only by IAPP.  Error bars are standard deviations from three sets of 
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Supplementary Figure 6:  Assessment of effect of small molecules on cell viability.  INS-1 cells 
were incubated with 13 µM of each of the indicated small molecules in a manner matched to that used 
for work shown in the main text (Fig. 4a). Viability was assayed after 48 h using CTB and compared to 
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Supplementary Figure 7: Solubility of ADM-116 in aqueous buffer.  a, Diffusion of 13 μM 
ADM-116 with 25 nM ADM-116F measured by FCS in 20 mM Tris, pH 7.4, 10 mM NaCl.  A fit to a 
function that includes only a single diffusible species (τD =100 ± 20 s) is shown (red, see Methods).  
Residuals of the fit are shown below the main data. b, 1H NMR spectrum of the aromatic and amide 
region of ADM-116.  Conditions were 20 μM ADM-116 in 50 mM phosphate buffer, pH 7.4, 100 mM 
KCl. NMR spectrum was recorded on an Agilent DD2 NMR spectrometer at 600 MHz.   
 
 




Supplementary Figure 8:  Effect of ADM-116 on the assembly kinetics of IAPP20-29.  Representative 
kinetic profile of amyloid assembly by 200 µM of the 10-residue peptide, IAPP20-29.  Reactions are 
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Supplementary Figure 9:  Colocalisation of IAPP and ADM-3.  INS-1 cells were exposed to a 
rescued condition (13 M IAPP and 15 M ADM-3) doped with 200 nM ADM-3F and 100 nM 
IAPPA594). a,  IAPP and small molecule were added at the same time to culture media.  b, ADM-3 was 











Time of IAPP addition: 0h, Time of ADM-3 addition: 0h
Time of IAPP addition: 0h, Time of ADM-3 addition: 20h
ADM-3 IAPP merge
a




Supplementary Figure 10:  ADM-116 induced conformational changes.  a, Visible CD spectra of 
25 M ADM-116 or ADM-116P in the presence of liposome (630 M in monomer units, DOPG:DOPC, 
1:1, 100 nm) and 25 M IAPP.  b, Far-UV CD spectra of 25 µM IAPP in the presence of ADM-116 or 
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Supplementary Figure 11:  Determination of background FRET in confocal imaging.  Confocal 
imaging and processing for FRET was conducted in a manner matched to that used in the main text 
(Fig. 7c,d).  Preparation of the cells was also matched except that the 100 nM IAPP594 was augmented 
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Supplementary Figure 12. 
1
H NMR of 5. 
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Supplementary Figure 14. 
1
H NMR of 6. 
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Supplementary Figure 16. 
1
H-NMR of 8. 
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Supplementary Figure 17. MALDI-TOF of 8. 
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Supplementary Figure 18. 
1
H-NMR of 9. 
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Supplementary Figure 19. MALDI-TOF of 9. 
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Supplementary Figure 20. 
1
H-NMR of 10. 
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Supplementary Figure 22. 
1
H-NMR of 11. 
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Supplementary Figure 23. MALDI-TOF of 11. 
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Supplementary Figure 24. 
1
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Supplementary Figure 25. MALDI-TOF of 12. 
 
  








Supplementary Figure 26. 
1
H-NMR of 13. 
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Supplementary Figure 27. MALDI-TOF of 13. 
  












Supplementary Figure 28. 
1
H-NMR of tert-butyl of ADM-116׀. 
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Supplementary Figure 29. MALDI-TOF of Tert-butyl of ADM-116׀. 
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Supplementary Figure 30. 
1
H-NMR of tert-butyl of ADM-116׀. 
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Supplementary Figure 31. MALDI-TOF of tert-butyl of ADM-116׀. 
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Supplementary Figure 32. 
1
H-NMR of tert-butyl of ADM-116P. 
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Supplementary Figure 33. MALDI-TOF of tert-butyl of ADM-116P. 
 
page 34 of 84 
 Supplementary Figure 34. 
1
H-NMR of ADM-116. 
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Supplementary Figure 35. ESI-MS of ADM-116. 
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Supplementary Figure 36. RP-HPLC of ADM-116.
 
 




























Supplementary Figure 37. 
1
H-NMR of ADM-116׀. 
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Supplementary Figure 38. ESI-MS of ADM-116׀. 
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Supplementary Figure 39. RP-HPLC of ADM-116׀. 
 
 



























Supplementary Figure 40. 
1
H-NMR of ADM-116׀.  
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 Supplementary Figure 41. ESI-MS of ADM-116׀. 
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Supplementary Figure 43. 
1
H-NMR of ADM-116P. 
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 Supplementary Figure 44. ESI-MS of ADM-116P. 
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Supplementary Figure 46. 
1
H-NMR of ADM-116M. 
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Supplementary Figure 47. ESI-MS of ADM-116M. 
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Supplementary Figure 48. RP-HPLC of ADM-116M. 
 



























Supplementary Figure 49. 
1
































Supplementary Figure 50. ESI-MS of tert-butyl ADM-3-NCS. 
 
 




























Supplementary Figure 51. 
1
H-NMR of tert-butyl ADM-3F. 
 
 




























Supplementary Figure 52. ESI-MS of tert-butyl ADM-3F. 
 
 




























Supplementary Figure 53. 
1
H-NMR of ADM-3F. 
 
 




























Supplementary Figure 54. ESI-MS of ADM-3F. 
 
 





























Supplementary Figure 55. RP-HPLC trace of ADM-3F. 
 





























Supplementary Figure 56. 
1
H-NMR of ADM-116F. 
 





























Supplementary Figure 57. ESI-MS of ADM-116F. 
 





























Supplementary Figure 58. RP-HPLC trace of ADM-116F. 
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Supplementary Figure 59. Synthesis of monomer quinoline precursors. 
 
 
Supplementary Figure 60. Generic representation for the synthesis of oligoquinolines. (a) 2-chloro-1-
methylpyridinium iodide, dichloromethane (anhydrous), trimethylamine (anhydrous), 12 h, 50 °C. (b) H2 (g), 
Pd/C, ethylacetate, 12 h, r.t. (c) 2, 2-chloro-1-methylpyridinium iodide, dichloromethane, trimethylamine, 12 
h, 50 °C. (d) H2 (g), Pd/C, ethylacetate, 12 h, r.t. (e) 6, 2-chloro-1-methylpyridinium iodide, dichloromethane 
(anhydrous), trimethylamine (anhydrous), 12 h, 50 °C. (f) Triflouroacetic acid, dichloromethane, triethylsilane, 
4 h, r.t. 
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Supplementary Figure 61. Synthesis of ADM-116׀. (a) 2-chloro-1-methylpyridinium iodide, 
dichloromethane (anhydrous), trimethylamine (anhydrous), 12 h, 50 °C. (b) H2 (g), Pd/C, ethylacetate, 
12 h, r.t. (c) 6, 2-chloro-1-methylpyridinium iodide, dichloromethane, trimethylamine, 12 h, 50 °C. (d) 
H2 (g), Pd/C, ethylacetate, 12 h, r.t. (e) 2, 2-chloro-1-methylpyridinium iodide, dichloromethane 
(anhydrous), trimethylamine (anhydrous), 12 h, 50 °C. (f) H2 (g), Pd/C, ethylacetate, 12 h, r.t. (g) 6, 2-
chloro-1-methylpyridinium iodide, dichloromethane (anhydrous), trimethylamine (anhydrous), 12 h, 50 
°C. (h) Triflouroacetic acid, dichloromethane, triethylsilane, 4 h, r.t. 
 
 
Supplementary Figure 62. Synthesis of ADM-116׀. (a) H2 (g), Pd/C, ethylacetate, 12 h, r.t. (b) 2, 2-
chloro-1-methylpyridinium iodide, dichloromethane (anhydrous), trimethylamine (anhydrous), 12 h, 
50 °C. (c) Triflouroacetic acid, dichloromethane, triethylsilane, 4 h, r.t. 
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Supplementary Figure 63. Synthesis of ADM-116F. (a) Ethylene diamine, 4-dimethylaminopyridine, 
50 °C, 20 h. (b) Triflouroacetic acid, dichloromethane, 4 h, r.t. (c) Fluorescein-5-isothiocyanate, 
pyridine (anhydrous), N,N-diisopropylethylamine (anhydrous), 20 h, r.t. 
 
 
Supplementary Figure 64. Synthesis of ADM-3F. (a) H2 (g), Pd/C, tetrahydrofuran, 4 h, r.t. (b) 1,1'-
thiocarbonyldi-2,2'-pyridone, dichloromethane (anhydrous), 12 h, r.t. (c) 5-
(Aminoacetamido)Fluorescein, dichloromethane (anhydrous), N,N-diisopropylethylamine (anhydrous), 
20 h, r.t. (d) Triflouroacetic acid, dichloromethane (anhydrous), triethylsilane, 4 h, r.t. 
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Supplementary Figure 65. Synthesis of ADM-116P and ADM-116M. (a) H2 (g), Pd/C, 
ethylacetate, 12 h, r.t. (b) (1S)-(−)-Camphanic chloride or (1R)-(+)-Camphanic chloride, 
trimethylamine (anhydrous), chloroform (anhydrous), 15 min. at 0° C and then 24 h at r.t. (c) 














page 63 of 84 




























ADM-116 2.8 ± 0.3 1.0 ± 0.1 -510 ± 120 -1.7 ± 0.3 -470 ± 90 -37 ± 4 
ADM-Ι 116 0.9 ± 0.2 0.8 ± 0.1 -82 ± 8 -0.17 ± 0.03 -49 ± 9 -33 ± 7 
ADM-116P 1.1 ± 0.1 0.9 ± 0.1 -1100 ± 70 -3.7 ± 0.2 -1070 ± 70 -34 ± 3 
 
Binding affinities.  ITC-derived thermodynamic parameters for the binding of the indicated ligands 
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Supplementary Table 2 
 










11  78 
12  83 
13  71 
ADM-116 74 
Tert-butyl ADM-69 116׀ 
ADM-72 116׀ 
Tert-butyl ADM-11672 ׀ 
ADM-11666 ׀ 
Tert-butyl ADM-116P 62 
ADM-116P 67 
Tert-butyl ADM-116M 64 
ADM-116M 68 
page 65 of 84 
ADM-116F 25% (overall yield for three steps) 
Tert-butyl ADM-3-NH2 98% 
Tert-butyl ADM-3-NCS 91% 
Tert-butyl ADM-3F 76% 
ADM-3F 72% 
 
% yield. A combined % yield for the monomeric precursors and the oligomers of oligoquinolines used 
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Supplementary Methods 




To a solution of 4 (5 g, 20 mmol) in acetone/ dimethylformamide (160 mL, 
15:1 v/v), sodium carbonate (4.1 g, 30 mmol) was added followed by ethyl 
iodide (3.2 mL, 40 mmol) under an inert atmosphere. The solution was 
stirred overnight at 70 °C under an inert atmosphere. The volatiles were 
removed on rotovap and the reaction mixture was dissolved in ethylacetate (300 mL) and water (300 
mL). The water layer was washed with ethylacetate (2 × 100 mL). The organic solutions were collected 
and successively washed (2 × each) with water (20 mL), 0.5 M solution of HCl (20 mL), and with brine 
(20 mL), dried over sodium sulfate and evaporated under vacuum to afford 5 as a pale yellow solid (3.3 
g, 60%) which was recrystallised in CHCl3/ MeOH (120, 1:4 v/v). TLC (Hexane:Ethylacetate, 70:30 
v/v): RF=0.7; 
1
H NMR (400 MHz, Chloroform-d) δ 8.53 – 8.40 (dd, J = 8.5, 1.4 Hz, 1H), 8.19 – 8.04 
(dd, J = 7.5, 1.4 Hz, 1H), 7.68 – 7.66 (s, 1H), 7.65 – 7.61 (m, 1H), 4.45 – 4.35 (q, J = 7.0 Hz, 2H), 4.06 
– 4.01 (s, 3H), 1.65 – 1.59 (t, J = 7.0 Hz, 4H). MS (MALDI-TOF) calcd for C13H12N2O5 (M+H+), 
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To a solution of 5 (2.0 g, 7.2 mmol) in tetrahydrofuran (100 mL), lithium 
hydroxide (0.2 N) in water (55 mL) was adeed and the solution was stirred for 
45 min. Acetic acid (conc.) was then added  with constant stirring to bring 
down the pH to ~4. To this reaction mixture, dichloromethane (200 mL) was 
added and the organic layer was successively washed once with water (20 mL) and brine (20 mL), dried 
over sodium sulfate, filtered, and evaporated to afford compound 6 as a yellow solid (Table 1 for % 
yield). 
1
H NMR (400 MHz, Chloroform-d) δ 8.59 – 8.51 (dd, J = 8.5, 1.4 Hz, 1H), 8.26 – 8.20 (dd, J = 7.5, 1.4 
Hz, 1H), 7.76 – 7.69 (m, 2H), 4.50 – 4.41 (q, J = 7.0 Hz, 2H), 1.68 – 1.62 (t, J = 7.0 Hz, 3H).  MS 
(MALDI-TOF) (m/z): calculated for C12H10N2O5
 
[(M+H)+]: 262.22, found 262.70. 
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Standard protocol for reduction of nitro-oligoquinolines 
To a solution of nitroquinoline (0.1-0.5 mmol) in ethylacetate (10 mL), Pd/C (10% wt.) was added and 
the reaction started with constant stirring at r. t. in the atmosphere of H2 (g). The progress of the reaction 
was monitored by TLC. Generally, the reduction reactions were completed in 12 h. The reaction mixture 
was filtered and dried which result in a yellow solid with quantitative yield. The product was used in the 
next step without further characterisation.  
Standard protocol for amide coupling  
To a solution of COOH nitroquinoline (0.12  mmol) in anhydrous dichloromethane (10 mL), 
triethylamine (0.4 mmol, anhydrous) and 2-chloromethyl-1-methyl pyridinium iodide (0.12 mmol) were 
added and the reaction was refluxed for 20 min. at 50 
°
C under inert atmosphere. To this solution, 
amino-oligoquinoline (0.1 mmol) was added and reaction started with constant stirring at 50 
°
C under 
inert atmosphere. The reaction mixture was stirred for 12 h after which the volatiles were removed on 
rotovap. Flash chromatography (0 to 35% ethylacetate in hexane, v/v) yielded the desired product as a 
yellow to brown solid.  
Standard protocol for deprotection of oligoquinolines  
To a solution of oligoquinoline (0.04 mmol), in dichloromethane (2 mL), triethylsilane (0.1 mL, excess) 
and trifluoroacetic acid (0.5 mL, excess) were added and the reaction solution was stirred at r.t. for 4 h. 
The reaction mixture was dried and washed with cold diethyl ether (4 × 3 mL) which resulted in a 
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Tert-butyl ADM-3  
Synthsis and characterisation of tert-butyl ADM-3 was reported elsewhere
2
. 
 To a solution of tert-butyl ADM-3 (30 mg, 0.04 mmol) in 
tetrahydrofuran (5 mL), Pd/C (5 mg) was added and the reaction 
started with constant stirring in the atmosphere of H2 (g) at r. t. The 
progress of the reaction was monitored using TLC. The disappearance 
of the starting material confirms the completion of the reaction (after 6 
h). The reaction mixture was filtered and the filterate was dried over 
rotovap to afford the desired product as a yellow solid (26.5 mg, 95%). 
TLC (Hexane:Ethylacetate, 60:40 v/v): RF=0.55. 
 
To a solution of tert-butyl ADM-3-NH2 (25 mg, 0.036 mmol) in 
dichloromethane (5 mL, anhydrous), 1,1' thiocarbonyldi-2,2'-pyridone 
(10 mg, 0.043 mmol, 1.2 eq.,) was added and the reaction was started 
with continuous stirring under inert atmosphere. The reaction solution 
was stirred overnight and then the product was purified using column 
charomatography (24 mg, 91%). TLC (Hexane:Ethylacetate, 70:30 v/v): 
RF=0.76; 
1
H NMR (400 MHz, Chloroform-d) δ 10.52 – 10.33 (s, 1H), 
10.22 – 10.05 (s, 1H), 9.10 – 8.89 (dd, J = 8.2, 2.7 Hz, 2H), 8.06 – 8.00 
(m, 1H), 7.99 – 7.91 (t, J = 8.0 Hz, 2H), 7.90 – 7.84 (d, J = 8.1 Hz, 1H), 
5.02 – 4.97 (d, J = 2.0 Hz, 4H), 4.48 – 4.43 (d, J = 6.8 Hz, 2H), 3.97 – 
3.91 (s, 3H), 1.50 – 1.46 (s, 10H), 1.46 – 1.41 (s, 9H), 1.17 – 1.14 (s, 
3H). MS (MALDI-TOF) calcd for C34H39N6O11S (M+H
+
), 739.2398, obsd: 739.2368.  
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TLC (dichloromethane:methanol:triethylamine, 83:17:0.5, 
v/v/v): RF=0.6; 
1
H NMR (500 MHz, DMSO-d6) δ 10.81 – 
10.58 (s, 1H), 10.43 – 10.31 (s, 1H), 10.10 – 10.04 (s, 1H), 
9.97 – 9.89 (s, 1H), 9.14 – 9.03 (d, J = 8.3 Hz, 2H), 8.90 – 
8.85 (d, J = 8.0 Hz, 1H), 8.84 – 8.78 (d, J = 8.1 Hz, 1H), 
8.35 – 8.31 (m, 1H), 7.92 – 7.88 (d, J = 8.0 Hz, 1H), 7.87 – 
7.80 (m, 3H), 7.28 – 7.16 (d, J = 8.3 Hz, 1H), 6.67 – 6.64 
(d, J = 2.3 Hz, 2H), 6.61 – 6.57 (d, J = 8.7 Hz, 2H), 6.55 – 
6.50 (dd, J = 8.7, 2.4 Hz, 2H), 5.15 – 5.07 (s, 2H), 5.03 – 
4.96 (s, 2H), 4.51 – 4.45 (m, 2H), 4.43 – 4.37 (d, J = 6.8 
Hz, 2H), 3.89 – 3.78 (s, 3H), 1.43 – 1.39 (s, 9H), 1.35 – 
1.32 (s, 9H), 1.12 – 1.10 (s, 3H). MS (MALDI-TOF) calcd 
for C56H55N8O17S (M+H
+









page 71 of 84 
ADM-3F 
1
H NMR (600 MHz, DMSO-d6) δ 13.47 – 12.91 
(s, 2H), 10.81 – 10.56 (s, 1H), 10.50 – 10.32 (s, 
1H), 10.17 – 10.01 (s, 3H), 10.04 – 9.88 (s, 1H), 
9.13 – 9.07 (d, J = 8.4 Hz, 2H), 8.92 – 8.87 (d, J = 
7.9 Hz, 1H), 8.85 – 8.80 (d, J = 8.0 Hz, 1H), 8.34 
– 8.26 (d, J = 1.9 Hz, 1H), 7.92 – 7.88 (d, J = 8.0 
Hz, 1H), 7.88 – 7.84 (dd, J = 8.1, 4.0 Hz, 2H), 
7.83 – 7.79 (dd, J = 8.4, 2.0 Hz, 1H), 7.26 – 7.19 
(d, J = 8.3 Hz, 1H), 6.67 – 6.62 (d, J = 2.3 Hz, 
2H), 6.61 – 6.56 (d, J = 8.6 Hz, 2H), 6.54 – 6.52 
(d, J = 2.3 Hz, 1H), 6.52 – 6.50 (d, J = 2.4 Hz, 
1H), 5.19 – 5.11 (s, 2H), 5.12 – 5.05 (s, 2H), 4.51 
– 4.43 (d, J = 4.8 Hz, 2H), 4.42 – 4.32 (d, J = 6.9 
Hz, 2H), 3.87 – 3.78 (s, 3H), 1.06 – 1.04 (s, 3H). 
MS (MALDI-TOF) calcd for C48H39N8O17S 
(M+H
+
), 1031.2154, obsd: 1031.2156. 
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TLC (Hexane:Ethylacetate, 60:40 v/v): RF=0.62; 
1
H NMR (400 
MHz, Chloroform-d) δ 11.87 – 11.79 (s, 1H), 9.13 – 9.04 (dd, J = 
7.7, 1.2 Hz, 1H), 8.51 – 8.45 (dd, J = 8.3, 1.3 Hz, 1H), 8.19 – 
8.13 (dd, J = 7.5, 1.4 Hz, 1H), 8.11 – 8.03 (dd, J = 8.4, 1.3 Hz, 
1H), 7.70 – 7.58 (dt, J = 14.4, 8.0 Hz, 2H), 7.55 – 7.51 (s, 1H), 
7.42 – 7.34 (t, J = 7.8 Hz, 1H), 4.88 – 4.78 (s, 2H), 4.48 – 4.36 
(q, J = 7.3 Hz, 2H), 4.25 – 4.16 (s, 3H), 1.64 – 1.58 (t, J = 7.0 Hz, 3H), 1.53 – 1.48 (s, 9H). MS 
(MALDI-TOF) calcd for C29H28N4O9 (M+H
+
), 576.18, obsd: 576.03. 
 
 
TLC (Hexane:Ethylacetate, 60:40 v/v): RF=0.55; 
1
H NMR (400 MHz, Chloroform-d) δ 12.26 – 
12.21 (s, 1H), 12.18 – 12.13 (s, 1H), 9.09 – 8.98 
(ddd, J = 13.8, 7.7, 1.3 Hz, 2H), 8.49 – 8.41 (dd, J 
= 8.4, 1.5 Hz, 1H), 8.18 – 8.11 (dd, J = 8.4, 1.3 Hz, 
1H), 8.06 – 7.97 (dd, J = 8.4, 1.3 Hz, 1H), 7.95 – 
7.90 (s, 1H), 7.82 – 7.67 (m, 3H), 7.64 – 7.56 (dd, 
J = 7.5, 1.5 Hz, 1H), 7.48 – 7.35 (m, 1H), 6.72 – 6.67 (s, 1H), 4.96 – 4.89 (s, 2H), 4.65 – 4.60 (s, 2H), 
4.57 – 4.47 (q, J = 6.9 Hz, 2H), 3.47 – 3.41 (s, 3H), 1.74 – 1.64 (t, J = 7.0 Hz, 3H), 1.68 – 1.53 (m, 
18H). MS (MALDI-TOF) calcd for C45H44N6O13 (M+H
+
), 876.88, obsd: 875.26. 
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TLC (Hexane:Ethylacetate, 60:40 
v/v): RF=0.42; 
1
H NMR (400 MHz, 
Chloroform-d) δ 12.34 – 12.26 (s, 
1H), 11.91 – 11.84 (s, 1H), 11.69 – 
11.61 (s, 1H), 9.15 – 9.08 (dd, J = 
7.6, 1.2 Hz, 1H), 8.61 – 8.52 (dd, J 
= 8.4, 1.4 Hz, 1H), 8.44 – 8.35 (dd, 
J = 7.7, 1.2 Hz, 1H), 8.23 – 8.15 
(dd, J = 7.7, 1.2 Hz, 1H), 8.12 – 8.06 (dd, J = 8.4, 1.2 Hz, 1H), 8.04 – 7.95 (ddd, J = 8.6, 6.2, 1.2 Hz, 
2H), 7.77 – 7.76 (s, 1H), 7.75 – 7.70 (t, J = 8.1 Hz, 1H), 7.65 – 7.57 (m, 2H), 7.48 – 7.44 (s, 1H), 7.42 – 
7.32 (m, 2H), 6.89 – 6.85 (s, 1H), 6.64 – 6.59 (s, 1H), 4.99 – 4.87 (s, 2H), 4.73 – 4.58 (m, 4H), 4.26 – 
4.14 (d, J = 7.5 Hz, 2H), 3.49 – 3.37 (s, 3H), 1.80 – 1.73 (t, J = 7.0 Hz, 3H), 1.61 – 1.58 (s, 9H), 1.60-
1.55 (m, 3H), 1.53 – 1.50 (s, 9H). MS (MALDI-TOF) calcd for C57H54N8O15 (M+H
+




TLC (Hexane:Ethylacetate, 70:30 v/v): RF=0.60; 
1
H NMR (400 
MHz, Chloroform-d) δ 11.93 – 11.80 (s, 1H), 9.10 – 9.03 (dd, J = 
7.8, 1.3 Hz, 1H), 8.67 – 8.58 (dd, J = 8.4, 1.4 Hz, 1H), 8.27 – 8.17 
(dd, J = 7.5, 1.4 Hz, 1H), 8.04 – 7.98 (dd, J = 8.4, 1.3 Hz, 1H), 7.89 – 
7.86 (s, 1H), 7.73 – 7.66 (dd, J = 8.5, 7.5 Hz, 1H), 7.66 – 7.60 (m, 
2H), 4.98 – 4.89 (s, 2H), 4.44 – 4.33 (q, J = 7.0 Hz, 2H), 4.24 – 4.18 (s, 3H), 1.64 – 1.57 (t, J = 7.0 Hz, 
3H), 1.54 – 1.53 (s, 9H). MS (MALDI-TOF) calcd for C29H28N4O9 (M+H
+
), 576.18, obsd: 576.12. 
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TLC (Hexane:Ethylacetate, 70:30 v/v): RF=0.51; 
1
H 
NMR (400 MHz, Chloroform-d) δ 12.22 – 12.20 (s, 1H), 
12.19 – 12.16 (s, 1H), 9.04 – 8.99 (m, 1H), 8.98 – 8.91 
(m, 1H), 8.51 – 8.43 (dd, J = 8.2, 1.4 Hz, 1H), 8.17 – 
8.07 (m, 1H), 7.93 – 7.88 (m, 2H), 7.77 – 7.72 (s, 1H), 
7.72 – 7.66 (td, J = 8.1, 3.8 Hz, 2H), 7.56 – 7.52 (dd, J = 7.6, 1.7 Hz, 1H), 7.38 – 7.32 (t, J = 7.9 Hz, 
1H), 6.80 – 6.65 (s, 1H), 4.95 – 4.89 (s, 2H), 4.57 – 4.42 (q, J = 7.0 Hz, 2H), 4.18 – 4.02 (q, J = 7.0 Hz, 
2H), 3.46 – 3.41 (s, 3H), 1.72-1.51 (m, 15H). MS (MALDI-TOF) calcd for C41H38N6O11 (M+H
+
), 
790.26, obsd: 789.93. 
 
 
TLC (Hexane:Ethylacetate, 70:30 v/v): 
RF=0.43; 
1
H NMR (500 MHz, Chloroform-
d) δ 12.33 – 12.27 (s, 1H), 11.92 – 11.87 (s, 
1H), 11.71 – 11.62 (s, 1H), 9.22 – 9.12 (d, J 
= 7.6 Hz, 1H), 8.68 – 8.63 (dd, J = 8.3, 1.5 
Hz, 1H), 8.39 – 8.33 (d, J = 7.5 Hz, 1H), 
8.11 – 8.07 (dd, J = 8.5, 1.3 Hz, 1H), 8.02 – 7.97 (m, 3H), 7.95 – 7.90 (dd, J = 8.4, 1.3 Hz, 1H), 7.88 – 
7.86 (s, 1H), 7.83 – 7.75 (t, J = 8.0 Hz, 1H), 7.64 – 7.60 (t, J = 8.2 Hz, 1H), 7.59 – 7.54 (m, 2H), 7.51 – 
7.46 (t, J = 7.9 Hz, 1H), 6.84 – 6.78 (s, 1H), 6.75 – 6.66 (s, 1H), 5.05 – 5.00 (s, 2H), 4.73 – 4.67 (s, 2H), 
4.22 – 4.13 (q, J = 6.9 Hz, 2H), 3.86 – 3.79 (q, J = 7.2 Hz, 3H), 3.46 – 3.46 (s, 3H), 1.75 – 1.68 (t, J = 
7.0 Hz, 4H), 1.63 – 1.62 (s, 9H), 1.56 – 1.55 (s, 9H), 1.40 – 1.34 (t, J = 7.2 Hz, 3H). MS (MALDI-TOF) 
calcd for C57H54N8O15 (M+H
+
), 1191.10, obsd: 1190.81. 
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1
H NMR (600 MHz, DMSO-d6) δ 11.77 (s, 1H), 11.74 (s, 1H), 10.51 – 10.41 (s, 3H), 8.91 – 8.77 (dd, J 
= 8.1, 2.6 Hz, 1H), 8.63 – 8.53 (d, J = 8.6 Hz, 1H), 8.17 – 8.12 (m, 1H), 8.12 – 8.07 (dd, J = 9.0, 4.4 Hz, 
2H), 7.86 – 7.81 (dd, J = 8.3, 2.2 Hz, 4H), 7.61 – 7.57 (m, 1H), 7.57 – 7.54 (d, J = 4.1 Hz, 1H), 7.48 – 
7.39 (dt, J = 15.6, 7.8 Hz, 2H), 7.25 – 7.22 (d, J = 8.2 Hz, 2H), 7.18 – 7.15 (m, 1H), 7.15 – 7.11 (m, 2H), 
6.66 – 6.65 (d, J = 2.5 Hz, 2H), 6.61 – 6.60 (s, 1H), 6.60 – 6.59 (s, 1H), 6.57 – 6.54 (dd, J = 8.5, 2.1 Hz, 
2H), 3.75 – 3.70 (q, J = 6.2 Hz, 2H), 3.64 – 3.52 (dt, J = 14.6, 7.2 Hz, 4H), 3.45 – 3.35 (dt, J = 15.2, 5.6 
Hz, 4H), 3.23 – 3.17 (p, J = 7.0 Hz, 2H), 1.23 – 1.20 (t, J = 7.1 Hz, 3H), 0.99 – 0.96 (t, J = 7.5 Hz, 3H). 
MS (MALDI-TOF) calcd for C71H53N11O19S (M+H
+
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To a solution of 14 (26.5 mg, 25 μM) 
in chloroform (5 mL, anhydrous), 
trimethylamine (7 μL, anhydrous) was 
added and the reaction was stirred at 0 
°C for 15 min. under inert atmosphere. 
To this reaction mixture, a slution of 
(1S)-(-) camphanyl chloride or (1R)-
(+) camphanyl chloride (5.5 mg, 25 
μM) in CHCl3 (3 mL, anhydrous) was 
added dropwise at 0 °C under inert 
atmosphere. The reaction mixture was stirred for 15 min. at 0 °C and then for 24 h at r.t. The solvents 
were removed on rotovap and the desired product was purified using column chromatography (0 to 50% 
ethylacetate in hexane, v/v) as a pale yellow solid (see Table 1 for % yield). TLC (Hexane:Ethylacetate, 
50:50 v/v): RF=0.45; 
1
H NMR (400 MHz, Chloroform-d) δ 12.49 – 12.43 (s, 1H), 11.89 – 11.83 (s, 1H), 
11.80 – 11.71 (s, 1H), 9.94 – 9.84 (s, 1H), 9.06 – 8.93 (m, 1H), 8.60 – 8.51 (m, 1H), 8.09 – 8.04 (dd, J = 
8.3, 1.3 Hz, 1H), 8.02 – 7.94 (m, 3H), 7.93 – 7.91 (s, 1H), 7.71 – 7.66 (t, J = 8.0 Hz, 2H), 7.65 – 7.59 (t, 
J = 8.0 Hz, 1H), 7.59 – 7.56 (s, 1H), 7.54 – 7.49 (m, 1H), 7.41 – 7.39 (s, 1H), 7.34 – 7.28 (m, 1H), 6.80 
– 6.76 (s, 1H), 6.62 – 6.60 (s, 1H), 4.94 – 4.84 (d, J = 2.9 Hz, 2H), 4.72 – 4.58 (m, 3H), 4.58 – 4.45 (m, 
2H), 4.27 – 4.11 (dq, J = 9.7, 3.3 Hz, 2H), 3.53 – 3.45 (s, 3H), 2.35 – 2.22 (m, 2H), 2.08 – 1.95 (m, 1H), 
1.83 – 1.72 (t, J = 7.0 Hz, 4H), 1.62 – 1.56 (s, 11H), 1.57 – 1.49 (s, 11H), 1.43 – 1.36 (s, 4H), 0.80 – 
0.76 (s, 3H), 0.75 – 0.71 (s, 3H). MS (MALDI-TOF) calcd for C67H68N8O16 (M+H
+
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TLC (Hexane:Ethylacetate, 
60:40 v/v): RF=0.38; 
1
H NMR 
(500 MHz, Chloroform-d) δ 
11.98 – 11.95 (s, 1H), 11.77 – 
11.74 (s, 1H), 11.74 – 11.72 (s, 
1H), 11.57 – 11.52 (s, 1H), 8.66 
– 8.60 (dd, J = 8.3, 1.4 Hz, 1H), 
8.52 – 8.47 (ddd, J = 7.5, 4.8, 1.3 Hz, 2H), 8.23 – 8.16 (ddd, J = 11.9, 7.6, 1.2 Hz, 2H), 8.13 – 8.08 (dd, 
J = 8.3, 1.2 Hz, 1H), 8.08 – 8.06 (dd, J = 2.2, 1.2 Hz, 1H), 8.06 – 8.01 (m, 2H), 7.96 – 7.92 (dd, J = 8.2, 
1.3 Hz, 1H), 7.71 – 7.63 (dt, J = 16.0, 8.0 Hz, 2H), 7.59 – 7.51 (m, 2H), 7.51 – 7.50 (s, 1H), 7.47 – 7.42 
(m, 2H), 7.37 – 7.31 (t, J = 8.0 Hz, 1H), 6.86 – 6.82 (s, 1H), 6.75 – 6.71 (s, 1H), 6.54 – 6.51 (s, 1H), 
5.07 – 5.01 (d, J = 5.1 Hz, 2H), 5.02 – 4.96 (dq, J = 17.2, 1.7 Hz, 1H), 4.95 – 4.91 (ddt, J = 10.0, 2.3, 1.3 
Hz, 1H), 4.71 – 4.68 (d, J = 5.4 Hz, 1H), 4.67 – 4.64 (d, J = 2.9 Hz, 2H), 4.60 – 4.53 (dd, J = 15.6, 8.9 
Hz, 2H), 4.52 – 4.48 (ddd, J = 6.0, 3.5, 1.2 Hz, 3H), 1.83 – 1.74 (m, 6H), 1.69 – 1.63 (s, 9H), 1.65 – 1.61 
(s, 9H), 1.55 – 1.50 (s, 9H). MS (MALDI-TOF) calcd for C73H70N10O19 (M+H
+
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TLC (Hexane:Ethylacetate, 50:50 
v/v): RF=0.42; 
1
H NMR (400 MHz, 
Chloroform-d) δ 11.98 – 11.95 (s, 
1H), 11.78 – 11.72 (d, J = 3.1 Hz, 
2H), 11.56 – 11.51 (s, 1H), 8.59 – 
8.54 (dd, J = 8.3, 1.5 Hz, 1H), 8.54 
– 8.44 (m, 2H), 8.24 – 8.14 (ddd, J 
= 15.6, 8.1, 1.2 Hz, 2H), 8.14 – 8.07 (ddd, J = 8.4, 3.5, 1.2 Hz, 2H), 8.05 – 7.95 (ddd, J = 17.3, 8.4, 1.2 
Hz, 2H), 7.85 – 7.80 (dd, J = 8.4, 1.2 Hz, 1H), 7.70 – 7.61 (m, 2H), 7.50 – 7.49 (d, J = 1.6 Hz, 1H), 7.42 
– 7.38 (m, 2H), 7.38 – 7.34 (m, 2H), 6.80 – 6.77 (s, 1H), 6.76 – 6.73 (s, 1H), 6.59 – 6.56 (s, 1H), 5.07 – 
5.01 (d, J = 2.6 Hz, 2H), 4.76 – 4.69 (d, J = 8.6 Hz, 2H), 4.52 – 4.44 (m, 2H), 4.14 – 4.07 (m, 2H), 3.92 
– 3.82 (m, 2H), 3.20 – 3.17 (s, 3H), 1.85 – 1.73 (t, J = 7.0 Hz, 3H), 1.67 – 1.64 (d, J = 7.0 Hz, 3H), 1.62 
– 1.61 (s, 10H), 1.60 – 1.57 (d, J = 6.7 Hz, 3H), 1.53 – 1.51 (s, 9H). MS (MALDI-TOF) calcd for 
C69H64N10O17 (M+H
+
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1
H NMR (600 MHz, DMSO-d6) δ 13.69 – 
13.15 (s, 2H), 12.12 – 12.03 (s, 1H), 11.69 
– 11.59 (s, 1H), 11.53 – 11.43 (s, 1H), 
9.02 – 8.99 (dd, J = 7.5, 1.3 Hz, 1H), 8.54 
– 8.51 (dd, J = 8.2, 1.4 Hz, 1H), 8.41 – 
8.38 (dd, J = 7.5, 1.3 Hz, 1H), 8.01 – 7.97 
(dd, J = 7.6, 1.3 Hz, 1H), 7.95 – 7.92 (dd, 
J = 8.4, 1.3 Hz, 1H), 7.92 – 7.90 (dd, J = 8.4, 1.3 Hz, 1H), 7.89 – 7.86 (dd, J = 8.4, 1.3 Hz, 1H), 7.80 – 
7.79 (d, J = 2.7 Hz, 1H), 7.79 – 7.75 (m, 2H), 7.72 – 7.68 (dd, J = 7.5, 1.4 Hz, 1H), 7.63 – 7.59 (dd, J = 
8.3, 7.5 Hz, 1H), 7.50 – 7.46 (m, 1H), 7.35 – 7.30 (s, 1H), 6.85 – 6.80 (s, 1H), 6.61 – 6.57 (s, 1H), 5.39 – 
5.07 (m, 2H), 5.03 – 4.76 (m, 2H), 4.76 – 4.50 (m, 2H), 4.39 – 4.08 (dd, J = 68.0, 11.0 Hz, 2H), 3.35 – 
3.32 (s, 3H), 1.73 – 1.68 (t, J = 7.0 Hz, 3H), 1.54 – 1.49 (t, J = 7.0 Hz, 3H). HRMS-ESI (m/z): 
calculated for C49H39N8O15
+
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1
H NMR (500 MHz, DMSO-d6) 
δ 14.04 – 12.77 (s, 3H), 11.69 – 
11.61 (s, 1H), 11.54 – 11.48 (s, 
1H), 11.48 – 11.43 (s, 1H), 
11.34 – 11.27 (s, 1H), 8.51 – 
8.41 (m, 2H), 8.40 – 8.32 (d, J = 
7.5 Hz, 1H), 8.02 – 7.98 (d, J = 7.6 Hz, 1H), 7.98 – 7.95 (d, J = 8.4 Hz, 1H), 7.94 – 7.90 (d, J = 8.3 Hz, 
1H), 7.87 – 7.84 (d, J = 8.3 Hz, 1H), 7.83 – 7.76 (m, 2H), 7.75 – 7.71 (t, J = 8.0 Hz, 1H), 7.70 – 7.66 (d, 
J = 8.2 Hz, 1H), 7.55 – 7.50 (m, 2H), 7.50 – 7.45 (t, J = 8.0 Hz, 1H), 7.37 – 7.33 (t, J = 8.0 Hz, 1H), 
7.32 – 7.30 (s, 1H), 7.21 – 7.15 (s, 1H), 6.76 – 6.68 (s, 1H), 6.68 – 6.62 (s, 1H), 6.44 – 6.39 (s, 1H), 5.25 
– 5.17 (d, J = 4.0 Hz, 2H), 4.98 – 4.90 (d, J = 16.1 Hz, 1H), 4.88 – 4.79 (m, 2H), 4.74 – 4.61 (m, 2H), 
4.62 – 4.53 (m, 1H), 4.33 – 4.22 (dq, J = 9.6, 7.0 Hz, 1H), 4.18 – 4.09 (dq, J = 9.5, 6.8 Hz, 1H), 3.09 – 
2.98 (s, 3H), 1.72 – 1.63 (t, J = 6.9 Hz, 3H), 1.56 – 1.46 (t, J = 6.9 Hz, 3H). HRMS-ESI (m/z): 
calculated for C61H47N10O19
+
 [(M+H)+]: 1223.3031, found 1223.3031. 
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1
H NMR (400 MHz, DMSO-d6) δ 
13.91 – 12.89 (br, s, 2H), 11.71 – 
11.66 (s, 1H), 11.58 – 11.51 (d, J = 
9.4 Hz, 2H), 11.36 – 11.31 (s, 1H), 
8.55 – 8.46 (m, 2H), 8.40 – 8.33 (d, 
J = 7.5 Hz, 1H), 8.07 – 7.93 (m, 
3H), 7.91 – 7.78 (m, 3H), 7.77 – 7.68 (m, 2H), 7.60 – 7.48 (m, 3H), 7.42 – 7.33 (m, 2H), 7.23 – 7.18 (s, 
1H), 6.79 – 6.74 (s, 1H), 6.70 – 6.65 (s, 1H), 6.54 – 6.49 (s, 1H), 5.28 – 5.21 (d, J = 4.8 Hz, 2H), 5.02 – 
4.84 (m, 3H), 4.76 – 4.59 (ddd, J = 32.6, 9.6, 7.0 Hz, 2H), 4.27 – 4.06 (m, 4H), 3.15 – 3.07 (s, 3H), 1.79 
– 1.66 (t, J = 6.9 Hz, 3H), 1.60 – 1.48 (dt, J = 13.6, 6.9 Hz, 6H). HRMS-ESI (m/z): calculated for 
C61H49N10O17
+
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1
H NMR (600 MHz, DMSO-d6) δ 12.25 – 12.20 (s, 1H), 11.65 – 11.61 (s, 1H), 11.61 – 11.56 (s, 1H), 
9.80 – 9.69 (s, 1H), 8.98 – 8.88 (d, J = 7.4 Hz, 1H), 8.50 – 8.44 (d, J = 7.6 Hz, 1H), 7.93 – 7.87 (m, 2H), 
7.87 – 7.82 (m, 3H), 7.82 – 7.75 (m, 2H), 7.73 – 7.68 (t, J = 8.0 Hz, 1H), 7.63 – 7.59 (s, 1H), 7.44 – 7.36 
(dt, J = 13.7, 7.9 Hz, 2H), 7.27 – 7.22 (s, 1H), 6.77 – 6.72 (s, 1H), 6.58 – 6.55 (s, 1H), 5.23 – 4.92 (d, J 
= 35.7 Hz, 4H), 4.72 – 4.51 (m, 3H), 4.34 – 4.17 (m, 2H), 2.03 – 1.89 (ddd, J = 18.8, 9.7, 5.3 Hz, 3H), 
1.74 – 1.66 (t, J = 7.0 Hz, 3H), 1.61 – 1.51 (t, J = 6.9 Hz, 4H), 1.49 – 1.30 (m, 2H), 0.86 – 0.78 (t, J = 
6.9 Hz, 2H), 0.72 – 0.67 (s, 3H), 0.67 – 0.63 (s, 3H). HRMS-ESI (m/z): calculated for C59H53N8O16
+
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1
H NMR (600 MHz, DMSO-d6) δ 12.24 – 12.19 (s, 1H), 11.66 – 11.61 (s, 1H), 11.58 – 11.54 (s, 1H), 
9.77 – 9.71 (s, 1H), 8.95 – 8.92 (d, J = 7.5 Hz, 1H), 8.46 – 8.41 (d, J = 7.5 Hz, 1H), 7.91 – 7.87 (d, J = 
8.4 Hz, 2H), 7.87 – 7.82 (m, 3H), 7.81 – 7.78 (d, J = 7.6 Hz, 1H), 7.76 – 7.72 (t, J = 7.9 Hz, 1H), 7.72 – 
7.68 (t, J = 7.9 Hz, 1H), 7.59 – 7.54 (s, 1H), 7.42 – 7.36 (t, J = 8.0 Hz, 2H), 7.28 – 7.24 (s, 1H), 6.76 – 
6.71 (s, 1H), 6.55 – 6.51 (s, 1H), 5.02 – 4.84 (m, 2H), 4.73 – 4.52 (ddd, J = 68.5, 9.3, 7.0 Hz, 2H), 4.53 
– 4.40 (d, J = 23.7 Hz, 2H), 4.33 – 4.19 (m, 2H), 3.40 – 3.37 (s, 3H), 2.01 – 1.98 (d, J = 7.5 Hz, 3H), 
1.73 – 1.67 (t, J = 6.9 Hz, 4H), 1.60 – 1.54 (t, J = 7.0 Hz, 4H), 1.46 – 1.40 (t, J = 7.2 Hz, 2H), 1.09 – 
1.04 (d, J = 6.6 Hz, 3H). HRMS-ESI (m/z): calculated for C59H53N8O16
+
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